To better understand why some cancer patients struggle to fight off infections, Georgia Tech researchers have created tiny ...

Scientists have developed a groundbreaking cancer treatment that works like a precision-guided missile with a powerful immune ...

ALLO-316, a CD70-targeting CAR T-cell therapy, has demonstrated activity in patients with previously treated, advanced ccRCC.

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

Completed Pre-Biologics License Application (BLA) meeting with the U.S. Food and Drug Administration (FDA) and remain on track to submit a BLA ...

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

The study added to a limited database about the effects of perioperative IO combinations, which have emerged as standard of ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

The citrus bioflavonoids market is projected to grow from $1.08 billion in 2023 to $1.2 ... anti-inflammatory, and immune-boosting properties. They are often used in supplements to support ...